Redefining the HIV-infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission

Transfusion

Volumn 39, Issue 7, 1999, Pages 688-693

  Murthy, K K ^a   Henrard, D R ^b   Eichberg, J W ^b   Cobb, K E ^b   Busch, M P ^b   Allain, J P ^b   Alter, H J ^b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CELL DNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD TRANSFUSION; CHIMPANZEE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; NONHUMAN; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DNA, VIRAL; HIV INFECTIONS; PAN TROGLODYTES; POLYMERASE CHAIN REACTION; RNA, VIRAL; TIME FACTORS;

EID: 0032811475     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39070688.x     Document Type: Article

References (19)

1. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
2. Busch MP, Lee LLL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human inmmunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
3. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102:117-24; discussion 125-6.
4. Lee TH, Stromberg RR, Busch MP, et al. Effect of platelet-associated virus on assays of HIV-1 in plasma. Science 1993;262:1585-6.
5. Petersen LR, Satten GA, Dodd R, et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 1994;34:283-9.
6. McCullough J, Bianco C, Busch M, et al. Interagency Genome Amplification Testing Task Force: preliminary report (editorial). Transfusion 1994;38:903-4.
7. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
8. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
9. Alter HJ, Eichberg JW, Masur H, et al. Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science 1984;226:549-52.
10. Arthur LO, Bess JW Jr, Waters DJ, et al. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficienty virus envelope glycoprotein gp120. J Virol 1989;63:5046-53.
11. Emini EA, Nara PL, Schleif WA, et al. Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees. J Virol 1990;64:3674-8.
12. Murthy KK, Cobb EK, el-Amad Z, et al. Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. AIDS Res Hum Retroviruses 1996;12:1341-8.
13. Coombs RW, Henrard DR, Mehaffey WF, et al. Cell-free plasma human immunodeficiency virus type l titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol 1993;31:1980-6.
14. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-8.
15. Hollinger FB. AIDS Clinical Trials Group manual for HIV laboratories, version 2.0. Bethesda, MD: ACTG, 1993.
16. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.
17. Cooper DA, Imrie AA, Penny R. Antibody response to human immunodeficiency virus after primary infection. J Infect Dis 1987;155:1113-8.
18. Ranki A, Valle SL, Krohn M, et al. Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet 1987;2:589-93.
19. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.